期刊文献+

阿尔茨海默病血浆总抗氧化状态与同型半胱氨酸水平的临床研究 被引量:4

Study on the relationship between plasma total anti-oxidant status and homocysteine(Hcy) levels in the diagnosis of Alzheimer's disease
下载PDF
导出
摘要 目的探讨血浆总抗氧化状态(TAS)和同型半胱氨酸水平(Hcy)在阿尔茨海默病(AD)中的发病机制。方法选择浦东新区精神卫生中心门诊AD患者198例,以酶法检测血浆TAS与Hcy水平。此期间选择健康体检者77例作对照组对比分析。结果 AD患者组血浆TAS和Hcy水平与正常对照组比较差异有统计学意义(P均<0.01);AD患者血浆TAS与Hcy水平呈明显负相关(r=-0.545,P<0.01)。结论高Hcy血症(HHcy)导致机体抗氧化能力下降,TAS水平的持续低下是AD发病的又一个重要原因。 Objective To study the relationship between plasma total anti-oxidant status (TAS) and homocysteine (Hey) levels in the diagnosis of Alzheimer's disease (AD). Methods 198 subjects were selected from outpatients of Shanghai Pudong New Area Mental Health Center and their plasma was tested for the items of TAS and Hcy levels by enzy- matic methods. Results There were significant differences in TAS and Hcy levels between the test group and control group ( both P 〈 0. 01 ). Conclusions There was close association between plasma TAS and Hcy levels in AD group. The hypohomocysteinemia(HHcy) may cause the lowing of plasma TAS levels, which can be one of the most important indicators in the diagnosis of AD.
出处 《实用老年医学》 CAS 2011年第1期50-51,55,共3页 Practical Geriatrics
关键词 阿尔茨海默病 总抗氧化状态 同型半胱氨酸 Alzheimer's disease total antioxidant status homocysteine
  • 相关文献

参考文献5

二级参考文献23

  • 1Ozkan Y, Ozkan E, Simsek B. Plasma tatal homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease[ J ]. Int J Cardio1,2002,82 ( 3 ) :269-277.
  • 2Kellogg MD, Parker R, Ricupero A, et al. Evaluation of an enzymatic homocysteine assay for the Hitachi series chemistry analyzer [ J ]. Clin Chim Acta, 2005, 354 (1/2) : 117-122.
  • 3荆爱玉,张春虹,谢璇,王俊宏.老年2型糖尿病血浆同型半胱氨酸与糖尿病微血管病变关系研究[J].实用老年医学,2007,21(4):246-248. 被引量:5
  • 4The incidence of dementia in Canada. The Canadian Study of Health and Aging Working Group. Ne urology 2000;55(1):66-73.
  • 5McCaddon A, Davies G, Hudson P, et al. Total serum homocysteine in senile dementia of Alzheimer type.Int J Geriatr Psychiatry 1998;13(4):235-9
  • 6Ravaglia G, Forti P, Maioli F, et al. Homocysteine and cognitive function in healthy elderly community dwellers in Italy.Am J Clin Nutr 2003;77 (3):668-73
  • 7Teunissen CE, Blom AH, Van Boxtel MP, et al. Homocysteine: a marker for cognitive performance?A longitudinal follow-up study.J Nutr Health Aging2003;7(3): 153-9
  • 8Lipton SA, Kim WK, Choi YB, Kumar S, et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D\aspartate receptor. Proc Natl Acad Sci U S A 199727;94(11):5923-8
  • 9Graham IM, Daly LE, Refsum HM,et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.JAMA 1997;277(22): 1775-81
  • 10Vermeer SE, van Dijk EJ, Koudstaal PJ, et al. Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study.Ann Neurol 2002;51 (3):285-9

共引文献12

同被引文献29

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部